XCHC President & CEO, Robert Kane, Issues Cannabinoid Financial Industry Insight and Illustrates Possible Economic Impact to US Economy at Executive Breakfast
|
Feb-28-2013 |
XCHC Invites Shareholders and Stakeholders to Amplify the February 25 Lobby Day Efforts of the Americans for Safe Access Unity Conference, Act by Contacting Your State and Federal Elected Officials
|
Feb-26-2013 |
XCHC Releases Worldwide Growth Guidance For Its Cannabinoid Treatment Centers and Formulations Targeting Critical Human Ailments, Company Acts on Own Guidance
|
Feb-21-2013 |
XCHC Gets Set to Launch its Cannabinoid Based Phytiva European Brand Product Line, Issues Positive Update on Internal Technology Upgrades and Marketing Developments
|
Feb-21-2013 |
XCHC Provides Significant Operational Guidance on Maliseet Nation Partnership; Initial Planning Indicates 500-1000 Acres for Medical Cannabis Hospital Compound Comprised of Clinical Facilities, Clinical Research Labs, Organic Research, Dietary Programs
|
Feb-19-2013 |
XCHC Appoints Maliseet Nation Councilor Gerald Bear to Facilitate Agreement with Maliseet Nation, Oversee the Development & Operations of the Medical Treatment Center, Clinical Laboratory, Manufacturing & Production Facility, and Cannabis Grow Facility
|
Feb-15-2013 |
XCHC Signs Historic Agreement with WOLASTOKWIK NeGoot-Gook, Maliseet Nation at Tobique of Eastern Canada that Allows Medical Cannabis Hospitals, Laboratories, Clinics, for Cannabinoid Research & Treatments, Open to the World, All Full Compliance with Law
|
Feb-13-2013 |
X-Change Corporation and Newly-Appointed Senior Medical Advisor Steven B. Hopping, M.D., F.A.C.S., Enter Discussions on Developing a High-End Skincare Product Line
|
Feb-12-2013 |
Harvard-Trained Cosmetic Surgeon and Former President of the American Academy of Cosmetic Surgery, Steven B. Hopping, M.D., F.A.C.S., Appointed as Senior Medical Advisor of X-Change Corporation
|
Feb-11-2013 |
X-Change Corp. Quickly Advances to Testing Stage with Its 'Phytiva' Brand of Products
|
Jan-31-2013 |